oncology

Under the agreement, JFCR will join Parexel’s Global Site Alliance network for oncology clinical trials and providing more…

The International Agency for Research on Cancer (IARC) forecasts a 58 per cent surge in GI cancer cases by 2040 globally 

The drug is forecast to achieve peak sales of $788 million by 2029

KEYTRUDA is now approved for 14 indications across eight tumour types in India

Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug oxaliplatin

By 2029, the global market for ADC therapies in oncology is expected to be worth more than $36 billion

Venus Remedies also expects marketing authorisation from Iraq for another commonly prescribed cancer drug, gemcitabine, to enhance…

The approval for AstraZeneca molecule is based on the findings of TOPAZ-1, a Phase-3 global clinical trial with patients recruited…

The treatment would work by switching on LED lights embedded close to a tumour, which would then activate biotherapeutic drugs

Collaboration to create, develop, manufacture and commercialise new class of potential therapeutics combining the superior…